FMP

FMP

Enter

MIST - Milestone Pharmaceut...

Terminal Value of Milestone Pharmaceuticals Inc.(MIST), Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commerci

photo-url-https://financialmodelingprep.com/image-stock/MIST.png

Milestone Pharmaceuticals Inc.

MIST

NASDAQ

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans. The company was incorporated in 2003 and is headquartered in Montréal, Canada.

1.39 USD

-0.02 (-1.44%)

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep